Unknown

Dataset Information

0

Recognizing protein-ligand binding sites by global structural alignment and local geometry refinement.


ABSTRACT: Proteins perform functions through interacting with other molecules. However, structural details for most of the protein-ligand interactions are unknown. We present a comparative approach (COFACTOR) to recognize functional sites of protein-ligand interactions using low-resolution protein structural models, based on a global-to-local sequence and structural comparison algorithm. COFACTOR was tested on 501 proteins, which harbor 582 natural and drug-like ligand molecules. Starting from I-TASSER structure predictions, the method successfully identifies ligand-binding pocket locations for 65% of apo receptors with an average distance error 2 Å. The average precision of binding-residue assignments is 46% and 137% higher than that by FINDSITE and ConCavity. In CASP9, COFACTOR achieved a binding-site prediction precision 72% and Matthews correlation coefficient 0.69 for 31 blind test proteins, which was significantly higher than all other participating methods. These data demonstrate the power of structure-based approaches to protein-ligand interaction predictions applicable for genome-wide structural and functional annotations.

SUBMITTER: Roy A 

PROVIDER: S-EPMC3372652 | biostudies-literature | 2012 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Recognizing protein-ligand binding sites by global structural alignment and local geometry refinement.

Roy Ambrish A   Zhang Yang Y  

Structure (London, England : 1993) 20120503 6


Proteins perform functions through interacting with other molecules. However, structural details for most of the protein-ligand interactions are unknown. We present a comparative approach (COFACTOR) to recognize functional sites of protein-ligand interactions using low-resolution protein structural models, based on a global-to-local sequence and structural comparison algorithm. COFACTOR was tested on 501 proteins, which harbor 582 natural and drug-like ligand molecules. Starting from I-TASSER st  ...[more]

Similar Datasets

| S-EPMC2440426 | biostudies-literature
| S-EPMC5513668 | biostudies-literature
| S-EPMC2859123 | biostudies-literature
| S-EPMC2626596 | biostudies-literature
| S-EPMC3821077 | biostudies-literature
| S-EPMC10881975 | biostudies-literature
| S-EPMC5048063 | biostudies-literature
| S-EPMC6353097 | biostudies-literature
| S-EPMC3036769 | biostudies-literature
| S-EPMC8027200 | biostudies-literature